In its upcoming report, Moderna (MRNA) is predicted by Wall Street analysts to post quarterly loss of $3.47 per share, reflecting an increase of 4.1% compared to the same period last year. Revenues are forecasted to be $124.92 million, representing a year-over-year decrease of 63.7%.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Prior to a company's earn ...